The MedStar Georgetown Transplant Institute (MGTI) is a multidisciplinary program dedicated to providing solid organ transplants to the greater Washington D.C. community. The center is not only one of the largest in the country but also one of the few to perform all four abdominal transplants (kidney, liver, pancreas, small bowel) and transplant fellows will gain exposure to all of these types of transplants. With over 200 kidney transplants, 100 liver transplants, 25-30 pancreas transplants and 15 small bowel transplants performed annually, we can offer experience in all facets of solid organ transplantation.
Beyond the size of the program, the true strength at MGTI is the collaborative approach with all aspects of the transplant team working as part of an integrated transplant institute. In addition to transplant surgeons and transplant nephrologists, MGTI has a strong infrastructure including pathology, an on-site histocompatibility lab, a dedicated transplant floor and specialized transplant nursing to form one of the most comprehensive transplant centers in the country.
MGTI is centered at the MedStar Georgetown University Hospital. It is the primary location for all transplant surgical procedures as well as the inpatient transplant service. However, MGTI is a broad-reaching program with medical services provided at a number of offices located to provide better and more convenient care to the community. In addition to the primary locations at Medstar Georgetown University Hospital and Medstar Washington Hospital Center, satellite centers in Baltimore MD, Annandale VA, Clinton MD, Frederick MD, Annapolis MD, and Columbia, MD are open to provide transplant services to patients. We also work in coordination with the pediatric transplant program at Children's National Medical Center (CNMC) to provide pediatric kidney transplants for those patients under the age of 18.
The transplant nephrology fellowship is part of the overall academic mission of MGTI. In addition to supporting the transplant nephrology fellowship, MGTI trains fellows in transplant surgery and transplant hepatology. We have a broad patient base and a diverse population served with patients coming from northern Virginia, Washington D.C., Maryland, and Pennsylvania as well as consults from across the United States and internationally. Such a setting is ideal to host a transplant nephrology fellowship.
MGTI is involved in many active clinical trials. Current trials involve the use of HIV positive organs, the use of blood group A2 kidneys in B recipients, the role of ApoL1 mutations in transplant, the advantages of Maravaroc in treating HIV positive patients receiving kidney transplants, the use of novel agents to reduce delayed graft function, and the use of complement inhibitors in the treatment of antibody mediated rejection. The transplant institute maintains a staff of dedicated research coordinators which are available to support any investigator initiated proposals as well.